Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Estey

Showing results (51-60 of 204) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Treatment of newly diagnosed acute promyelocytic leukemia without cytarabineE Estey, P F Thall, S Pierce, et al.
Neurology|September 1, 1978
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson diseaseA Lieberman, E Estey, G Gopinathan, et al.
Cancer|March 1, 1995
Topotecan in chronic lymphocytic leukemiaS O'Brien, H Kantarjian, A Ellis, et al.
Investigational New Drugs|November 11, 1999
Phase I study of liposomal daunorubicin in patients with acute leukemiaJ Cortes, S O'Brien, E Estey, et al.
Leukemia|October 27, 1997
Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemiaE Estey, P Thall, H Kantarjian, et al.
Blood|October 24, 1997
Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapyE Estey, P Thall, M Beran, et al.
Leukemia|October 1, 1995
Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significanceS M Kornblau, P Thall, Y O Huh, et al.
Blood|July 15, 1996
A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemiaE Estey, S Kornblau, S Pierce, et al.
Leukemia|June 1, 2002
Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adultsJ H Rex, E J Anaissie, E Boutati, et al.
Blood|May 21, 1999
Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapyN Vey, M Keating, F Giles, et al.
Pageof 21

Showing results (51-60 of 204) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Treatment of newly diagnosed acute promyelocytic leukemia without cytarabineE Estey, P F Thall, S Pierce, et al.
Neurology|September 1, 1978
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson diseaseA Lieberman, E Estey, G Gopinathan, et al.
Cancer|March 1, 1995
Topotecan in chronic lymphocytic leukemiaS O'Brien, H Kantarjian, A Ellis, et al.
Investigational New Drugs|November 11, 1999
Phase I study of liposomal daunorubicin in patients with acute leukemiaJ Cortes, S O'Brien, E Estey, et al.
Leukemia|October 27, 1997
Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemiaE Estey, P Thall, H Kantarjian, et al.
Blood|October 24, 1997
Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapyE Estey, P Thall, M Beran, et al.
Leukemia|October 1, 1995
Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significanceS M Kornblau, P Thall, Y O Huh, et al.
Blood|July 15, 1996
A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemiaE Estey, S Kornblau, S Pierce, et al.
Leukemia|June 1, 2002
Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adultsJ H Rex, E J Anaissie, E Boutati, et al.
Blood|May 21, 1999
Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapyN Vey, M Keating, F Giles, et al.
Pageof 21